Literature DB >> 8643682

Core binding factor beta-smooth muscle myosin heavy chain chimeric protein involved in acute myeloid leukemia forms unusual nuclear rod-like structures in transformed NIH 3T3 cells.

C Wijmenga1, P E Gregory, A Hajra, E Schröck, T Ried, R Eils, P P Liu, F S Collins.   

Abstract

Patients with the M4Eo subtype of acute myeloid leukemia almost invariably are found to have an inversion of chromosome 16 in their leukemic cells, which results in a gene fusion between the transcription factor called core binding factor beta (CBFbeta) on 16q and a smooth muscle myosin heavy chain (SMMHC) gene on 16p. Subcellular localizations of the wild-type CBFbeta and the CBFbeta-SMMHC fusion protein were determined by immunofluorescence of NIH 3T3 cells that overexpress wild-type or fusion protein. Normal CBFbeta showed an unexpected perinuclear pattern consistent with primary localization in the Golgi complex. The CBFbeta-SMMHC fusion protein had a very different pattern. Nuclear staining included rod-like crystalline structures as long as 11 microm. The heterodimeric partner of CBFbeta, CBFalpha, formed part of this complex. Cytoplasmic staining included stress fibers that colocalized with actin, probably as a consequence of the myosin heavy chain component of the fusion protein. Deletion of different regions of the CBFbeta portion of the fusion protein showed that binding to CBFalpha was not required for nuclear translocation. However, deletion of parts of the SMMHC domain of the fusion protein involved in myosin-mediated filament formation resulted in proteins that did not form rod-like structures. These observations confirm previous indirect evidence that the CBFbeta-SMMHC fusion protein is capable of forming macromolecular nuclear aggregates and suggests possible models for the mechanism of leukemic transformation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8643682      PMCID: PMC39993          DOI: 10.1073/pnas.93.4.1630

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt.

Authors:  P Erickson; J Gao; K S Chang; T Look; E Whisenant; S Raimondi; R Lasher; J Trujillo; J Rowley; H Drabkin
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

2.  The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-gamma and -delta gene expression.

Authors:  Y H Hsiang; D Spencer; S Wang; N A Speck; D H Raulet
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

3.  Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells.

Authors:  M H Kryszke; J Piette; M Yaniv
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

4.  Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor.

Authors:  S Wang; Q Wang; B E Crute; I N Melnikova; S R Keller; N A Speck
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

5.  Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1.

Authors:  S C Bae; Y Yamaguchi-Iwai; E Ogawa; M Maruyama; M Inuzuka; H Kagoshima; K Shigesada; M Satake; Y Ito
Journal:  Oncogene       Date:  1993-03       Impact factor: 9.867

6.  Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor delta and murine leukemia virus enhancers.

Authors:  J M Redondo; J L Pfohl; C Hernandez-Munain; S Wang; N A Speck; M S Krangel
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

7.  Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha.

Authors:  E Ogawa; M Inuzuka; M Maruyama; M Satake; M Naito-Fujimoto; Y Ito; K Shigesada
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

8.  Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers.

Authors:  S W Wang; N A Speck
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

9.  A nucleation--elongation mechanism for the self-assembly of side polar sheets of smooth muscle myosin.

Authors:  R A Cross; M A Geeves; J Kendrick-Jones
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

10.  A microtubule-binding protein associated with membranes of the Golgi apparatus.

Authors:  V J Allan; T E Kreis
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  7 in total

1.  MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25).

Authors:  M Osaka; J D Rowley; N J Zeleznik-Le
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

Review 2.  Core Binding Factor Acute Myeloid Leukemia: New Prognostic Categories and Therapeutic Opportunities.

Authors:  Chandrima Sinha; Lea C Cunningham; Paul P Liu
Journal:  Semin Hematol       Date:  2015-04-07       Impact factor: 3.851

3.  Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues.

Authors:  David Waltregny; Laurence De Leval; Wendy Glénisson; Siv Ly Tran; Brian J North; Akeila Bellahcène; Ulrich Weidle; Eric Verdin; Vincent Castronovo
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

4.  PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.

Authors:  Hee-Jun Wee; Dominic Chih-Cheng Voon; Suk-Chul Bae; Yoshiaki Ito
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

5.  FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.

Authors:  Hyung-Gyoon Kim; Kyoko Kojima; C Scott Swindle; Claudiu V Cotta; Yongliang Huo; Vishnu Reddy; Christopher A Klug
Journal:  Blood       Date:  2007-10-29       Impact factor: 22.113

Review 6.  Core binding factor at the crossroads: determining the fate of the HSC.

Authors:  Kevin A Link; Fu-Sheng Chou; James C Mulloy
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

7.  The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates.

Authors:  N Adya; T Stacy; N A Speck; P P Liu
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.